---
title: "Brabourne Enterprises Ltd(merged) (BRABOURNE) — Share Price, Financials & Analysis"
symbol: "BRABOURNE"
company: "Brabourne Enterprises Ltd(merged)"
canonical: "https://tapetide.com/stocks/BRABOURNE"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:59:52.285Z"
---

# Brabourne Enterprises Ltd(merged) (BRABOURNE)

Canonical page: https://tapetide.com/stocks/BRABOURNE

## Company

- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- Company has a low return on equity of 8.98% over last 3 years.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -168% |
| revenue growth | -100% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 126 | 124 | 115 | 258 | 534 | 698 | 507 | 489 | 686 |
| Expenses | 52 | 48 | 47 | 171 | 296 | 346 | 300 | 300 | 374 |
| Operating Profit | 74 | 76 | 68 | 87 | 238 | 352 | 208 | 190 | 311 |
| OPM % | 59 | 61 | 59 | 34 | 45 | 50 | 41 | 39 | 45 |
| Other Income | 7 | 4 | 6 | 10 | 26 | 19 | 12 | 65 | 34 |
| Interest | 11 | 12 | 12 | 71 | 99 | 75 | 60 | 56 | 60 |
| Depreciation | 12 | 12 | 11 | 50 | 92 | 103 | 80 | 79 | 84 |
| Profit before tax | 57 | 56 | 51 | -24 | 73 | 193 | 80 | 120 | 200 |
| Tax % | 25 | 15 | 48 | 96 | 53 | 22 | 53 | 46 | 30 |
| Net Profit | 43 | 47 | 26 | -47 | 35 | 151 | 38 | 64 | 140 |
| EPS in Rs | 41.41 | 45.22 | 25.3 | -2.7 | 0.95 | 5.48 | 1.15 | 2.25 | 4.99 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 |
| --- | --- | --- | --- |
| Sales | 146 | 121 | 0 |
| Expenses | 120 | 99 | 29 |
| Operating Profit | 25 | 22 | -29 |
| OPM % | 17 | 18 | — |
| Other Income | 27 | 4 | 2 |
| Interest | 18 | 12 | 0 |
| Depreciation | 6 | 5 | 0 |
| Profit before tax | 28 | 10 | -27 |
| Tax % | 9 | 17 | 11 |
| Net Profit | 26 | 8 | -30 |
| Dividend Payout % | 14 | 26 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 |
| --- | --- | --- | --- |
| Equity Capital | 14 | 14 | 14 |
| Reserves | 51 | 57 | 48 |
| Borrowings | 97 | 85 | 1 |
| Other Liabilities | 59 | 43 | 1 |
| Total Liabilities | 222 | 200 | 65 |
| Fixed Assets | 30 | 26 | 1 |
| CWIP | 0 | 12 | 0 |
| Investments | 95 | 90 | 53 |
| Other Assets | 98 | 72 | 11 |
| Total Assets | 222 | 200 | 65 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 |
| --- | --- | --- | --- |
| Cash from Operating Activity | 44 | 15 | 0 |
| Cash from Investing Activity | 49 | -6 | 0 |
| Cash from Financing Activity | -66 | -28 | -3 |
| Net Cash Flow | 27 | -19 | -2 |
| Free Cash Flow | 39 | 2 | 0 |
| CFO/OP | 193 | 70 | -1 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 |
| --- | --- | --- | --- |
| Debtor Days | 64 | 74 | — |
| Inventory Days | 183 | 168 | — |
| Days Payable | 297 | 269 | — |
| Cash Conversion Cycle | -51 | -28 | — |
| Working Capital Days | 20 | 52 | — |
| ROCE % | — | 13 | 0 |

## Shareholding Pattern

### annual

| Category | Mar 2025 | Dec 2025 |
| --- | --- | --- |
| Promoters | 88.99% | 88.99% |
| FIIs | 2.92% | 1.56% |
| DIIs | 5.41% | 5.23% |
| Public | 2.69% | 4.24% |
| No. of Shareholders | 37687 | 30389 |

### Quarterly

| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 88.99% | 88.99% | 88.99% | 88.99% | 88.99% |
| FIIs | 3.31% | 2.92% | 2.68% | 1.66% | 1.56% |
| DIIs | 3.78% | 5.41% | 5.24% | 5.24% | 5.23% |
| Public | 3.93% | 2.69% | 3.09% | 4.11% | 4.24% |
| No. of Shareholders | 71296 | 37687 | 35235 | 33062 | 30389 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 6 / 6 / 7

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 205.9 | Buy |
| EMA (10) | 210.01 | Buy |
| SMA (20) | 211.24 | Buy |
| EMA (20) | 211.3 | Buy |
| SMA (50) | 220.36 | Sell |
| EMA (50) | 230.36 | Sell |
| SMA (100) | 282.43 | Sell |
| EMA (100) | 266.07 | Sell |
| SMA (200) | 338.09 | Sell |
| EMA (200) | 286.3 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.99 | Neutral |
| MACD (12,26,9) | -3.77 | Buy |
| Stochastic (14,3,3) | 58.69 | Neutral |
| ADX (14) | 23.62 | Neutral |
| Williams %R (14) | -46.51 | Neutral |
| ATR (14) | 11.31 | High Volatility |
| ROC (12) | 4.28 | Buy |
| Stoch RSI (14) | 80.3 | Sell |
| UO (7,14,28) | 53.9 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 7 Feb - Transcript of Earnings Call held on February 3, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 7 Feb - Transcript of Earnings Call held on February 3, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0a5662ef-9f78-465b-940e-bcea1af79e77.pdf) |
| 17 Feb - Subsidiary acquired 100% of Finest-VN for INR 59,83,00,000 on 17 Feb 2026; Soho House rights. | [Announcement under Regulation 30 (LODR)-Acquisition 17 Feb - Subsidiary acquired 100% of Finest-VN for INR 59,83,00,000 on 17 Feb 2026; Soho House rights.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae0b99d6-6418-4dcd-8177-43dee40be24a.pdf) |
| 12 Feb - Ventive to attend Kotak Flagship Conference in Mumbai on Feb 24, 2026; no unpublished price-sensitive information. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 12 Feb - Ventive to attend Kotak Flagship Conference in Mumbai on Feb 24, 2026; no unpublished price-sensitive information.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29a1866d-6aba-4630-85a0-97d23cf5801d.pdf) |
| 10 Feb - Release of encumbrance on 52,104,896 shares (22.31%) of Ventive Hospitality on 6 Feb 2026. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 10 Feb - Release of encumbrance on 52,104,896 shares (22.31%) of Ventive Hospitality on 6 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/A321E3DD_EC26_46FE_A919_6679560B7A31_172521.pdf) |
| — | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 10 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/C48212FE_9C4C_4A62_86F3_E218FEE1388E_152557.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a7d6fce-706f-4ab0-94c2-00d14293645f.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a45f27f9-62d8-44d9-801e-d70a12749bdf.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d79e6eb-db5e-4e36-9811-21d66058c8ed.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d326c97b-2a5e-4eec-926f-ba544884518f.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4cc05263-3dc9-41d0-b90f-773c6724d1bf.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/51aeb32c-f95e-45f5-b8bf-77d0089b0a65.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:59:52.285Z.